Cancer Research Institute Awards Over $22 Million in Grants to Fuel Immunotherapy Innovations NEW YORK – August 8, 2024 — As the leading nonprofit organization committed to revolutionizing cancer treatment... August 8, 2024August 8, 2024
Cancer Research Institute Announces New Lloyd J. Old STARs Class New York, NY – August 5, 2024 – The Cancer Research Institute (CRI) proudly announces the newest... August 5, 2024August 5, 2024
Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination Evaluating LOQTORZI® (toripalimab-tpzi) with ENB Therapeutics’ ENB-003 for the Treatment of Ovarian Cancer REDWOOD CITY, Calif., May 8, 2024 — Coherus BioSciences, Inc. (Coherus; Nasdaq: CHRS) today announced that the... May 8, 2024May 8, 2024
New Survey of U.S. Oncologists Reveals Where More Work Can Be Done to Research Treatments for Advanced Non-Small Cell Lung Cancer Survey examined oncologists’ perspective on treatment options and priorities, comorbidities and other clinical characteristics of patients with... January 24, 2024January 24, 2024
CRI CEO and Director of Scientific Affairs Dr. Jill O’Donnell-Tormey on Immunotherapy and Her Tenure NEW YORK – Jill O’Donnell-Tormey, PhD, CEO and director of scientific affairs at the Cancer Research Institute... December 21, 2023December 21, 2023
Cancer Research Institute Joins Lance Kawaguchi, #SouthPoleTrek4Cancer to Ring the Nasdaq Stock Market Closing Bell Contact: Melinda Koski, SouthPoleTrek4Cancer Sharon Slade, Chief Marketing Officer, CRI For Immediate Release Tuesday, December 19, 2023... December 19, 2023December 19, 2023
